ATE276355T1 - Verfahren zur konservierung von biologisch aktivem material - Google Patents

Verfahren zur konservierung von biologisch aktivem material

Info

Publication number
ATE276355T1
ATE276355T1 AT00938911T AT00938911T ATE276355T1 AT E276355 T1 ATE276355 T1 AT E276355T1 AT 00938911 T AT00938911 T AT 00938911T AT 00938911 T AT00938911 T AT 00938911T AT E276355 T1 ATE276355 T1 AT E276355T1
Authority
AT
Austria
Prior art keywords
active material
preserved
biologically
biologically active
coacervate
Prior art date
Application number
AT00938911T
Other languages
English (en)
Inventor
Eric Eward Worrall
Original Assignee
Anhydro Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhydro Ltd filed Critical Anhydro Ltd
Application granted granted Critical
Publication of ATE276355T1 publication Critical patent/ATE276355T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00938911T 1999-06-22 2000-06-21 Verfahren zur konservierung von biologisch aktivem material ATE276355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914412.3A GB9914412D0 (en) 1999-06-22 1999-06-22 Method for the preservation of viruses,bacteria and biomolecules
PCT/GB2000/002254 WO2000078924A1 (en) 1999-06-22 2000-06-21 Method for the preservation of biologically-active material

Publications (1)

Publication Number Publication Date
ATE276355T1 true ATE276355T1 (de) 2004-10-15

Family

ID=10855729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00938911T ATE276355T1 (de) 1999-06-22 2000-06-21 Verfahren zur konservierung von biologisch aktivem material

Country Status (9)

Country Link
US (1) US6841168B1 (de)
EP (1) EP1187907B1 (de)
CN (1) CN1168819C (de)
AT (1) ATE276355T1 (de)
AU (1) AU5413500A (de)
DE (1) DE60013821T2 (de)
ES (1) ES2228540T3 (de)
GB (1) GB9914412D0 (de)
WO (1) WO2000078924A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) * 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US20080064108A1 (en) * 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
AU2003230908A1 (en) * 2002-04-11 2003-10-27 Medimmune Vaccines, Inc. Spray freeze dry of compositions for intranasal administration
GB0225520D0 (en) * 2002-11-01 2002-12-11 Glaxosmithkline Biolog Sa Drying process
US20050118058A1 (en) * 2003-12-01 2005-06-02 Erning Xia Gentle preservative compositions for self-preserving solutions
EP1750760B1 (de) * 2004-06-02 2017-06-28 Universal Stabilization Technologies, Inc. Konservierung mittels verdampfung
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
CN100375636C (zh) * 2005-09-29 2008-03-19 中国农业大学 一种对微生态制剂有保护作用的糖类组合物的用途
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
EP1991204A2 (de) 2006-02-24 2008-11-19 Novartis AG Mikropartikel mit biologisch abbaubarem polymer und kationischem polysaccharid zur verwendung für immunogene zusammensetzungen
US8399230B2 (en) * 2006-10-12 2013-03-19 Kemin Industries, Inc. Heat-stable enzyme compositions
US20090081785A1 (en) 2007-09-24 2009-03-26 Hememics Biotechnologies, Inc. Desiccated Biologics And Methods Of Preparing The Same
US20090090022A1 (en) * 2007-10-09 2009-04-09 Hememics Biotechnologies, Inc. Desiccation Chamber and Methods for Drying Biological Materials
GB0900350D0 (en) * 2009-01-09 2009-02-11 Cambridge Entpr Ltd Formulations of viable bacteria for oral delivery
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
EP2547760A4 (de) 2010-02-17 2014-01-01 Hememics Biotechnologies Inc Konservierungslösungen für biologika und zugehörige verfahren
CL2011001984A1 (es) * 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
GB201101950D0 (en) * 2011-02-04 2011-03-23 Anhydro Ltd Vaccine compositions
US20120222979A1 (en) 2011-03-04 2012-09-06 Elwha LLC, a limited liability company of the State of Delaware Glassy compositions
PE20191242A1 (es) 2011-10-25 2019-09-16 Prothena Biosciences Ltd Formulaciones de anticuerpo y metodos
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
ES2978111T3 (es) 2015-06-25 2024-09-05 Native Microbials Inc Métodos, aparatos y sistemas para analizar cepas de microorganismos de comunidades heterogéneas complejas, predecir e identificar relaciones funcionales e interacciones de las mismas, y seleccionar y sintetizar conjuntos microbianos basados en las mismas
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
CN109757107A (zh) 2016-01-07 2019-05-14 埃斯库斯生物科技股份公司 用于通过施用微生物聚生体来提高乳产量的方法
EP3562954A1 (de) 2016-12-28 2019-11-06 Ascus Biosciences, Inc. Verfahren, vorrichtungen und systeme zur analyse von kompletten mikroorganismenstämmen in komplexen heterogenen gemeinschaften, bestimmung funktionaler beziehungen und interaktionen davon sowie identifizierung und synthetisierung darauf basierender bioreaktiver modifikatoren
JP2020503048A (ja) 2016-12-28 2020-01-30 アスカス バイオサイエンシーズ， インコーポレイテッド トレーサー分析論による複雑な不均一コミュニティの微生物株の解析、その機能的関連性及び相互作用の決定、ならびに微生物アンサンブル（投与される微生物アンサンブル及び接種される微生物アンサンブルを含む）の合成、のための方法、装置、及びシステム
US11044924B2 (en) 2017-04-28 2021-06-29 Native Microbials, Inc. Methods for supporting grain intensive and or energy intensive diets in ruminants by administration of a synthetic bioensemble of microbes or purified strains therefor
CN116096856A (zh) * 2020-08-28 2023-05-09 科·汉森有限公司 利用辛烯基琥珀酸酐淀粉-壳聚糖复合团聚体微囊化微生物培养物
CN112471476A (zh) * 2020-11-18 2021-03-12 山东丰香园食品股份有限公司 一种具有补脑及美白作用的芝麻粉及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
EP2275089A1 (de) * 1993-11-19 2011-01-19 Alkermes Controlled Therapeutics, Inc. Herstellung biologisch abbaubarer Mikropartikel, die einen biologisch aktiven Stoff enthalten
ATE239451T1 (de) * 1995-06-07 2003-05-15 Elan Drug Delivery Ltd Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US5900238A (en) * 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
JP2000514440A (ja) * 1996-07-09 2000-10-31 ザ ジョーンズ ホプキンス ユニバーシティー 遺伝子輸送システム
JP2001511174A (ja) * 1997-02-07 2001-08-07 クアドラント ホールディングス ケンブリッジ リミテッド 乾燥された、貯蔵安定性を有する血小板を製造するための方法及び組成物
AU5459698A (en) * 1997-11-26 1999-06-15 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification

Also Published As

Publication number Publication date
EP1187907A1 (de) 2002-03-20
DE60013821T2 (de) 2005-11-17
AU5413500A (en) 2001-01-09
GB9914412D0 (en) 1999-08-18
CN1168819C (zh) 2004-09-29
ES2228540T3 (es) 2005-04-16
US6841168B1 (en) 2005-01-11
DE60013821D1 (de) 2004-10-21
WO2000078924A1 (en) 2000-12-28
EP1187907B1 (de) 2004-09-15
CN1357037A (zh) 2002-07-03

Similar Documents

Publication Publication Date Title
ATE276355T1 (de) Verfahren zur konservierung von biologisch aktivem material
AP1521A (en) Method for the preservation of viruses and mycoplasma.
BR9804739A (pt) Processo para produção de produtos amorfos por meios de secagem por convecção
AR248426A1 (es) Produccion de particulas incorporadas a un virus vegetal que contiene un peptido antigenico, con el fin de preparar una vacuna de virus animal.
BR9611265A (pt) Preparações e processos para estabilização de materiais biológicos por meio de processos de secagem sem congelamento
JP2015145500A5 (de)
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
EP1255439A4 (de) Therapeutische plättchen und verfahren
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
EP1683812A4 (de) Mikroteilchen aus vernetztem polysaccharid und herstellungsverfahren dafür
MY166220A (en) Rabies virus like particle production in plants
ES8800601A1 (es) Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa)
HUP9902165A2 (hu) Nagy fajlagos felületű D-mannit, eljárás előállítására, valamint ilyen mannitot tartalmazó szilárd kompozíciók
ATE103976T1 (de) Verfahren zur verkapselung.
JP3790671B2 (ja) 人体および動植物生理活性促進物ならびにその製造方法
HRP921354A2 (en) Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes
GB2020976A (en) Microbial inseticides
ATE340272T1 (de) In gegenwart von collagen und disacchariden lyophilisierte nukleinsäuren umfassende zusammensetzung
FR2768747B1 (fr) Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
FR2620333B1 (fr) Liposomes, leur procede de preparation et application desdits liposomes comme vecteur de produits
RU98107302A (ru) Способ изготовления известково-песчаных строительных материалов
BR9813185A (pt) Processo para remoção das micotoxinas a partir de um carregamento de café verde
ATE340260T1 (de) Verfahren zur behandlung von tumoren mittels antiangiogener substanzen
DE68918269D1 (de) Pflanzenvirusbekämpfungsmittel und verfahren zur herstellung.
RU93028311A (ru) Способ получения биологически активных веществ из биомассы культивируемых клеток растений

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties